HomeLatestSensex opens with tepid commerce, monitoring weak world cues

Sensex opens with tepid commerce, monitoring weak world cues

Mumbai (Maharashtra) [India], April 19 (ANI): The key indices of home markets opened with losses for the third session this week as monetary shares dragged. Indices have been buying and selling tepid within the morning, monitoring weak world cues.

BSE Sensex misplaced 79 factors to 59,647.56 and NSE Nifty dropped 25 factors to 17,634.95. Some of the highest gainers on Nifty 50 have been MahindraMahindra, Tata Steel, Eicher Motors, Hindalco and LarsenToubro whereas the laggards have been ONGC, Hindustan Unilever, Apollo Hospital, Infosys and Asian Paints.

In Asian markets, Japan’s Nikkei misplaced 91 factors, Hong Kong’s Hang Seng dropped 130 factors and China’s Shanghai was buying and selling within the unfavourable territory on Wednesday morning.

In US markets, Dow Jones dipped 10 factors, Nasdaq and NYSE and SP have been buying and selling within the optimistic territory when the stock exchanges closed on Tuesday.

In European markets, BEL, CAC, and Deutsche have been buying and selling within the optimistic territory, FTSE 100 gained 29 factors and Madrid SE was additionally buying and selling within the optimistic territory.

“In the results expected this week, the best performance is likely to come from ICICI Bank. HCL Tech is unlikely to disappoint like Infosys. RIL’s results will be good but unlikely to surprise the market. Investors should closely watch the results that surprise on the upside along with positive management commentary. Such stocks will remain resilient even in a weak market,” mentioned V Okay Vijayakumar, Chief Investment Strategist at Geojit Financial Services.

On BSE, Bank of India shares went up 1.51 per cent to Rs 81.99. The lender’s board of administrators had authorised to boost capital as much as Rs 6,500 crore for 2023-24 (FY24). In one other growth, shares of Piramal Pharma surged 7.71 per cent to Rs 77.40 after the US regulator — FDA — accomplished its inspection of Piramal Pharma’s manufacturing facility positioned at Sellersville within the US. (ANI)

Source

Latest